About OISIN BIOTECHNOLOGIES, INC.
Oisín Biotechnologies is developing genetic medicines targeting the biology of aging using a non-viral delivery technology called Fusogenix™ Proteo-Lipid Vehicle (PLV). The company focuses on creating redosable, targetable therapies for age-related decline, including fat removal, muscle building, and longevity biology.
Is this your company?
Claim OISIN BIOTECHNOLOGIES, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim OISIN BIOTECHNOLOGIES, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.